Bone marrow transplantation to mice with an experimental model of tuberculosis
- Authors: Isaev A.A.1, Pospelov L.E.2, Bocharova I.V.2, Hegert V.Y.2, Stankov D.S.1, Prikhodko A.V.1, Avdienko V.G.2, Pospelov A.L.2
-
Affiliations:
- JSC "Institute of Human Stem Cells"
- GU Central Research Institute of Tuberculosis of the Russian Academy of Medical Sciences
- Issue: Vol 1, No 2 (2006)
- Pages: 51-54
- Section: Original Study Articles
- URL: https://genescells.ru/2313-1829/article/view/217718
- DOI: https://doi.org/10.23868/gc217718
- ID: 217718
Cite item
Open Access
Access granted
Abstract
The effectiveness of the use of bone marrow cells (CMC) in the treatment of experimental tuberculosis was investigated. It was shown that transplantation of allogeneic bone marrow cells from AKR mice resistant to tuberculosis to C57BL/6 mice sensitive to tuberculosis and infected with mycobacterium strain H37Rv significantly prolonged the life of infected experimental animals and reduced the number of mycobacteria seeded from organs compared with untreated animals. The study of humoral immunity showed that the introduction of allogeneic bone marrow cells leads to nonspecific polyisotypic stimulation of anti-tuberculosis antibodies, which is important in creating a protective humoral background. There was also a pronounced production of IgG2a antibodies in comparison with the level of IgG1 antibodies during therapy with bone marrow cells, which indicates the presence of a Tb1 response, which is clearly protective in tuberculosis. A high level of IgG2a antibodies correlated with a high level of a specific cellular immune response, assessed by a delayed-type hypersensitivity reaction (HRT).
Keywords
Full Text
About the authors
A. A. Isaev
JSC "Institute of Human Stem Cells"
Author for correspondence.
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
L. E. Pospelov
GU Central Research Institute of Tuberculosis of the Russian Academy of Medical Sciences
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
I. V. Bocharova
GU Central Research Institute of Tuberculosis of the Russian Academy of Medical Sciences
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
V. Ya. Hegert
GU Central Research Institute of Tuberculosis of the Russian Academy of Medical Sciences
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
D. S. Stankov
JSC "Institute of Human Stem Cells"
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
A. V. Prikhodko
JSC "Institute of Human Stem Cells"
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
V. G. Avdienko
GU Central Research Institute of Tuberculosis of the Russian Academy of Medical Sciences
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
A. L. Pospelov
GU Central Research Institute of Tuberculosis of the Russian Academy of Medical Sciences
Email: redaktor@celltranspl.ru
Russian Federation, Moscow
References
- Krishanan A. et al. Durable remission with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 2005; 105(2): 874-8.
- Lane H.C. et al. Syngenic bone marrow transplantation and adoptive transfer of peripheral blood lymphocytes combined with ridovudine in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 1990; 113: 512.
- Авербах М.М., Мороз А.М.,. Апт А.С., Никоненко В.В. Иммуногенетика инфекционных заболеваний. М., Медицина; 1985.
- Gros P., Skamene E., Forget A. Genetic control of natural resistance of mycobacterium bovis (BCG) in mice. J. Immunol. 1981; 127: 2417-21.
- Schwebach J.R., Casadevall A, Schneerson R. et al. Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo. Infect. Immun. 2001; 69(9): 5671-8.
- Hovav A.H., Fishman Y., Bercovier H. Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine. Infect. Immun. 2005; 73(1): 250-7.
- Wang Q.M., Sun S.H., Hu Z.L. et al. Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting. Vaccine 2004; 22(27-28): 3622-7.
- Williams A., Reljic R., Naylor I. et al. Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs. Immunology 2004; 111 (3): 328-33.
Supplementary files
